Moreover, a significantly increased AFAP1-AS1 level was also verified in HER-2 positive breast cancer tissues in contrast to HER-2 negative tissues (Fig. 1d), which strongly supports our hypothesis. The gene discussed is ERBB2; the disease is breast carcinoma.